These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25945126)

  • 1. Diagnostic accuracy of Bethesda system for reporting thyroid cytopathology: an institutional perspective.
    Naz S; Hashmi AA; Khurshid A; Faridi N; Edhi MM; Kamal A; Khan M
    Int Arch Med; 2014; 7():46. PubMed ID: 25945126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.
    Sullivan PS; Hirschowitz SL; Fung PC; Apple SK
    Cancer Cytopathol; 2014 Dec; 122(12):866-72. PubMed ID: 25078420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer rate of Bethesda category II thyroid nodules.
    Mulita F; Iliopoulos F; Tsilivigkos C; Tchabashvili L; Liolis E; Kaplanis C; Perdikaris I; Maroulis I
    Med Glas (Zenica); 2022 Feb; 19(1):. PubMed ID: 34734516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of malignancy rates in different diagnostic categories of the Bethesda system for reporting thyroid cytopathology: An institutional experience.
    Arul P; Akshatha C; Masilamani S
    Biomed J; 2015 Dec; 38(6):517-22. PubMed ID: 27013451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of atypia/follicular lesion of undetermined significance on the rate of malignancy in thyroid fine-needle aspiration: evaluation of the Bethesda System for Reporting Thyroid Cytopathology.
    Broome JT; Solorzano CC
    Surgery; 2011 Dec; 150(6):1234-41. PubMed ID: 22136846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To Establish Bethesda System for Diagnosis of Thyroid Nodules on the Basis of Fnac with Histopathological Correlation.
    Garg S; Desai NJ; Mehta D; Vaishnav M
    J Clin Diagn Res; 2015 Dec; 9(12):EC17-21. PubMed ID: 26816898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.
    Yaprak Bayrak B; Eruyar AT
    BMC Endocr Disord; 2020 Apr; 20(1):48. PubMed ID: 32293401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A histological assessment of the Bethesda system for reporting thyroid cytopathology (2010) abnormal categories: a series of 219 consecutive cases.
    Tepeoğlu M; Bilezikçi B; Bayraktar SG
    Cytopathology; 2014 Feb; 25(1):39-44. PubMed ID: 23438201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid Nodules Cytopathology Applying the Bethesda System with Histopathological Correlation.
    Zarif HA; Ghandurah SE; Al-Garni MA; Binmahfooz SK; Alsaywid BS; Satti MB
    Saudi J Med Med Sci; 2018; 6(3):143-148. PubMed ID: 30787841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On-site fine-needle aspiration cytology of thyroid nodules. Quality assurance of the Bethesda System for Reporting Thyroid Cytopathology (2008)].
    Bak M; Péter I; Nyári T; Simon P; Újlaky M; Boér A; Kásler M
    Orv Hetil; 2015 Oct; 156(41):1661-6. PubMed ID: 26551169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performances of the KWAK-TIRADS classification, elasticity score, and Bethesda System for Reporting Thyroid Cytopathology of TI-RADS category 4 thyroid nodules.
    Huang S; Meng N; Pan M; Yu B; Liu J; Deng K; Hu M; Zhou H; Qin C
    Int J Clin Exp Pathol; 2020; 13(5):1159-1168. PubMed ID: 32509090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of thyroid fine-needle aspiration cytology into Bethesda categories: An institutional experience and review of the literature.
    Alshaikh S; Harb Z; Aljufairi E; Almahari SA
    Cytojournal; 2018; 15():4. PubMed ID: 29531571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of impact of using the Bethesda System for Reporting Thyroid Cytopathology: an institutional experience.
    Kantola S; Virani N; Haus C; Hipp J; Zhao L; Jing X
    J Am Soc Cytopathol; 2015; 4(1):25-29. PubMed ID: 31051669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the bethesda system for reporting thyroid cytopathology and similar precursor thyroid cytopathology reporting schemes.
    Wong LQ; Baloch ZW
    Adv Anat Pathol; 2012 Sep; 19(5):313-9. PubMed ID: 22885380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid cytology-nuclear versus architectural atypia within the "Atypia of undetermined significance/follicular lesion of undetermined significance" Bethesda category have significantly different rates of malignancy.
    Gan TR; Nga ME; Lum JH; Wong WM; Tan WB; Parameswaran R; Ngiam KY
    Cancer Cytopathol; 2017 Apr; 125(4):245-256. PubMed ID: 28192631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yield of repeat fine-needle aspiration biopsy and rate of malignancy in patients with atypia or follicular lesion of undetermined significance: the impact of the Bethesda System for Reporting Thyroid Cytopathology.
    Chen JC; Pace SC; Chen BA; Khiyami A; McHenry CR
    Surgery; 2012 Dec; 152(6):1037-44. PubMed ID: 23040711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Implementation of the Bethesda system for reporting the thyroid cytopathology: study on 5 729 cases from a cancer center].
    Guo HQ; Zhao H; Cao J; Zhao LL; Sun Y; Wang C; Zhang ZH
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Mar; 55(3):258-262. PubMed ID: 32268696
    [No Abstract]   [Full Text] [Related]  

  • 18. Follicular lesion of undetermined significance in thyroid FNA revisited.
    Walts AE; Mirocha J; Bose S
    Diagn Cytopathol; 2014 Jan; 42(1):18-22. PubMed ID: 23894017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and Its Impact on the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience.
    Kim M; Kim JE; Kim HJ; Chung YR; Kwak Y; Park SY
    J Pathol Transl Med; 2018 May; 52(3):171-178. PubMed ID: 29614546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Institution-specific risk of papillary thyroid carcinoma in atypia/follicular lesion of undetermined significance.
    Bernstein JM; Shah M; MacMillan C; Freeman JL
    Head Neck; 2016 Apr; 38 Suppl 1():E1210-5. PubMed ID: 26268802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.